HMGB1 and Shock: In their study of 42 patients with septic shock, Gibot et al. noticed increases in HMGB1 levels between days 1 and 3 among nonsurvivors, whereas a progressive but statistically nonsignificant decrease was noted in HMGB1 levels among survivors30.